These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1526077)

  • 21. Potential mechanisms by which a single drink of alcohol can increase transdermal absorption of topically applied chemicals.
    Brand RM; Jendrzejewski JL; Charron AR
    Toxicology; 2007 Jun; 235(3):141-9. PubMed ID: 17467136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal administration of nicotine.
    Rose JE; Jarvik ME; Rose KD
    Drug Alcohol Depend; 1984 May; 13(3):209-13. PubMed ID: 6734425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stable isotope studies of nicotine kinetics and bioavailability.
    Benowitz NL; Jacob P; Denaro C; Jenkins R
    Clin Pharmacol Ther; 1991 Mar; 49(3):270-7. PubMed ID: 2007322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of chronopharmacokinetics in design and evaluation of transdermal drug delivery systems.
    Gries JM; Benowitz N; Verotta D
    J Pharmacol Exp Ther; 1998 May; 285(2):457-63. PubMed ID: 9580583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dermal and transdermal delivery of pharmaceutically relevant macromolecules.
    Münch S; Wohlrab J; Neubert RHH
    Eur J Pharm Biopharm; 2017 Oct; 119():235-242. PubMed ID: 28647443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical pharmacological study of subcutaneous nicotine.
    Le Houezec J; Jacob P; Benowitz NL
    Eur J Clin Pharmacol; 1993; 44(3):225-30. PubMed ID: 8491235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect and Mechanism of Transdermal Penetration Enhancement of Fu's Cupping Therapy: New Physical Penetration Technology for Transdermal Administration with Traditional Chinese Medicine (TCM) Characteristics.
    Xie WJ; Zhang YP; Xu J; Sun XB; Yang FF
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28346390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamic effects of nicotine nasal spray devices on cardiovascular and pulmonary function.
    Fishbein L; O'Brien P; Hutson A; Theriaque D; Stacpoole PW; Flotte T
    J Investig Med; 2000 Nov; 48(6):435-40. PubMed ID: 11094866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Advances in Skin Penetration Enhancers for Transdermal Gene and Drug Delivery.
    Amjadi M; Mostaghaci B; Sitti M
    Curr Gene Ther; 2017; 17(2):139-146. PubMed ID: 28494734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human pharmacological investigations of a transdermal nicotine system.
    Müller P; Imhof PR; Mauli D; Milovanovic D
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):197-204. PubMed ID: 2725118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal bioavailability and first-pass skin metabolism: a preliminary evaluation with nitroglycerin.
    Nakashima E; Noonan PK; Benet LZ
    J Pharmacokinet Biopharm; 1987 Aug; 15(4):423-37. PubMed ID: 3119815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro-in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence of transient heat application.
    Shin SH; Thomas S; Raney SG; Ghosh P; Hammell DC; El-Kamary SS; Chen WH; Billington MM; Hassan HE; Stinchcomb AL
    J Control Release; 2018 Jan; 270():76-88. PubMed ID: 29175139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of transdermal system containing nicotine by using sustained release dosage design.
    Tirnaksiz F; Yuce Z
    Farmaco; 2005 Sep; 60(9):763-70. PubMed ID: 16019001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transdermal therapeutic systems for drug administration].
    Hupfeld S; Gravem H
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Drug Delivery Kinetics to Epidermal Targets In Vivo.
    Hoppel M; Tabosa MAM; Bunge AL; Delgado-Charro MB; Guy RH
    AAPS J; 2021 Mar; 23(3):49. PubMed ID: 33782803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absolute bioavailability of nicotine applied to different nasal regions.
    Johansson CJ; Olsson P; Bende M; Carlsson T; Gunnarsson PO
    Eur J Clin Pharmacol; 1991; 41(6):585-8. PubMed ID: 1815971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics.
    Porchet HC; Benowitz NL; Sheiner LB; Copeland JR
    J Clin Invest; 1987 Nov; 80(5):1466-71. PubMed ID: 3680508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal Oxandrolone: Ex Vivo Percutaneous Absorption Study.
    Polonini H; de Oliveira Ferreira A; Raposo NRB; Brandão MAF
    Curr Drug Deliv; 2017; 14(5):696-700. PubMed ID: 27138297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of exercise on transdermal nicotine release in healthy habitual smokers.
    Bur A; Joukhadar C; Klein N; Herkner ; Mitulovic G; Schmid R; Agneter E; Müller M; Brunner M
    Int J Clin Pharmacol Ther; 2005 May; 43(5):239-43. PubMed ID: 15906589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin.
    Higaki K; Nakayama K; Suyama T; Amnuaikit C; Ogawara K; Kimura T
    Int J Pharm; 2005 Jan; 288(2):227-33. PubMed ID: 15620862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.